SMAD7 and colorectal carcinoma: Furthermore, bioinformatic predictions and experimental validation demonstrated that SMAD7 is a direct target of miR-25 in mCRC, and miR-25 inhibition could promote the migratory ability of CRC cells via the suppression of SMAD7 [203].